# Radiotherapy or Imiquimod in Complex Lentigo Maligna

> **NCT02394132** · PHASE3 · COMPLETED · sponsor: **Melanoma and Skin Cancer Trials Limited** · enrollment: 126 (actual)

## Conditions studied

- Lentigo Maligna

## Interventions

- **DRUG:** Imiquimod
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT02394132
- **Lead sponsor:** Melanoma and Skin Cancer Trials Limited
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-31
- **Primary completion:** 2021-12-24
- **Final completion:** 2023-03-30
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2024-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02394132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02394132, "Radiotherapy or Imiquimod in Complex Lentigo Maligna". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02394132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*